Skip to main content
EDSS variability before randomization may limit treatment discovery in primary progressive MS.
Relapse severity and recovery in early pediatric multiple sclerosis.
Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis.
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.